Home > Publications database > Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study. > print

001     178738
005     20240229143554.0
024 7 _ |a 10.1007/s10654-022-00843-y
|2 doi
024 7 _ |a pmid:35118581
|2 pmid
024 7 _ |a 0393-2990
|2 ISSN
024 7 _ |a 1573-7284
|2 ISSN
024 7 _ |a altmetric:122151728
|2 altmetric
037 _ _ |a DKFZ-2022-00233
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schlehofer, Brigitte
|0 P:(DE-He78)e9acc181eadf1c41b9a43639fc1c9faf
|b 0
|e First author
245 _ _ |a Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study.
260 _ _ |a Dordrecht [u.a.]
|c 2022
|b Springer Science + Business Media B.V.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1655974553_11774
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C030# / 2022 May;37(5):503-512
520 _ _ |a We investigated the association of allergic diseases and epilepsy with risk of brain tumours, in Interphone, a 13-country case-control study. Data were obtained from 2693 glioma cases, 2396 meningioma cases, and 1102 acoustic neuroma cases and their 6321 controls. Conditional logistic regression models were used to estimate pooled odds ratios (ORs) and their respective 95% confidence intervals (CIs), adjusted for education and time at interview. Reduced ORs were observed for glioma in relation to physician-diagnosed asthma (OR = 0.73; CI 0.58-0.92), hay fever (OR 0.72; CI 0.61-0.86), and eczema (OR 0.78, CI 0.64-0.94), but not for meningioma or acoustic neuroma. Previous diagnosis of epilepsy was associated with an increased OR for glioma (2.94; CI 1.87-4.63) and for meningioma (2.12; CI 1.27-3.56), but not for acoustic neuroma. This large-scale case-control study adds to the growing evidence that people with allergies have a lower risk of developing glioma, but not meningioma or acoustic neuroma. It also supports clinical observations of epilepsy prior to the diagnosis of glioma and meningioma.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Allergies
|2 Other
650 _ 7 |a Brain tumours
|2 Other
650 _ 7 |a Epilepsy
|2 Other
650 _ 7 |a Multicenter case–control study
|2 Other
700 1 _ |a Blettner, Maria
|b 1
700 1 _ |a Moissonnier, Monika
|b 2
700 1 _ |a Deltour, Isabelle
|0 0000-0002-6602-6292
|b 3
700 1 _ |a Giles, Graham G
|0 0000-0003-4946-9099
|b 4
700 1 _ |a Armstrong, Bruce
|b 5
700 1 _ |a Siemiatycki, Jack
|0 0000-0002-9042-8582
|b 6
700 1 _ |a Parent, Marie-Elise
|0 0000-0002-4196-3773
|b 7
700 1 _ |a Krewski, Daniel
|b 8
700 1 _ |a Johansen, Christoffer
|b 9
700 1 _ |a Auvinen, Anssi
|0 0000-0003-1125-4818
|b 10
700 1 _ |a Lahkola, Anna
|b 11
700 1 _ |a Hours, Martine
|b 12
700 1 _ |a Berg-Beckhoff, Gabriele
|0 0000-0003-1614-938X
|b 13
700 1 _ |a Sadetzki, Siegal
|b 14
700 1 _ |a Lagorio, Susanna
|0 0000-0001-8883-8745
|b 15
700 1 _ |a Takebayashi, Toru
|b 16
700 1 _ |a Yamaguchi, Naohito
|b 17
700 1 _ |a Woodward, Alistair
|b 18
700 1 _ |a Cook, Angus
|b 19
700 1 _ |a Tynes, Tore
|b 20
700 1 _ |a Klaboe, Lars
|b 21
700 1 _ |a Feychting, Maria
|0 0000-0002-5101-0060
|b 22
700 1 _ |a Feltbower, Richard
|b 23
700 1 _ |a Swerdlow, Anthony
|b 24
700 1 _ |a Schoemaker, Minouk
|b 25
700 1 _ |a Cardis, Elisabeth
|0 0000-0003-0999-6839
|b 26
700 1 _ |a Schüz, Joachim
|0 0000-0001-9687-2134
|b 27
773 _ _ |a 10.1007/s10654-022-00843-y
|0 PERI:(DE-600)2004992-4
|n 5
|p 503-512
|t European journal of epidemiology
|v 37
|y 2022
|x 0393-2990
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178738
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)e9acc181eadf1c41b9a43639fc1c9faf
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-01-28
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2022-11-17
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J EPIDEMIOL : 2021
|d 2022-11-17
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EUR J EPIDEMIOL : 2021
|d 2022-11-17
920 1 _ |0 I:(DE-He78)C030-20160331
|k C030
|l Umwelt-Epidemiologie
|x 0
920 0 _ |0 I:(DE-He78)C030-20160331
|k C030
|l Umwelt-Epidemiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C030-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21